Cancer Res. 2008 Mar
Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B
Abstract
T-cadherin delineates endothelial, myoepithelial, and ductal epithelial cells in the normal mouse mammary gland, and becomes progressively restricted to the vasculature during mammary tumorigenesis. To test the function of T-cadherin in breast cancer, we inactivated the T-cadherin (Cdh13) gene in mice and evaluated tumor development and pathology after crossing the mutation into the mouse mammary tumor virus (MMTV)-polyoma virus middle T (PyV-mT) transgenic model. We report that T-cadherin defic
...[more]iency limits mammary tumor vascularization and reduces tumor growth. Tumor transplantation experiments confirm the stromal role of T-cadherin in tumorigenesis. In comparison with wild-type MMTV-PyV-mT controls, T-cadherin-deficient tumors are pathologically advanced and metastasize to the lungs. T-cadherin is a suggested binding partner for high molecular weight forms of the circulating, fat-secreted hormone adiponectin. We discern adiponectin in association with the T-cadherin-positive vasculature in the normal and malignant mammary glands and report that this interaction is lost in the T-cadherin null condition. This work establishes a role for T-cadherin in promoting tumor angiogenesis and raises the possibility that vascular T-cadherin-adiponectin association may contribute to the molecular cross-talk between tumor cells and the stromal compartment in breast cancer.
[less]
Mesh Headings:
Adiponectin, Animals, Antigens, CD31, Cadherins, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Male, Mammary Neoplasms, Animal, Mice, Mice, Inbred C57BL, Mice, Transgenic, Neoplasm Metastasis, Neoplasm Transplantation, Neovascularization, Pathologic